TruSight® Tumor 26 takes a deeper view of variation in solid tumors including lung, colon,
melanoma, gastric, and ovarian. This step enables clinical researchers to look beyond point
mutations within hot spots in single genes for a more comprehensive view of somatic
variation. TruSight Tumor 26 provides amplicon-based library preparation reagents, DNA
QC, sample indexes, and oligos targeting identified regions of interest. Sufficient reagents
are supplied for 48 samples and the indexes provided enable indexing of 4 samples per sequencing run